PBH
Prestige Consumer Healthcare In
Drug Manufacturers - Specialty & Generic · Healthcare · United States
48.75
close · 2026-10-29
value
76
cheaper than peers76
quality
63
stronger fundamentals63
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.20× | 87 |
| forward P/E | 9.59× | 67 |
| EV to EBITDA | 13.48× | 50 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 24.6% | 79 |
| return on equity | 9.1% | 66 |
| revenue growth | 6.5% | 50 |
| debt to equity | 107.7% | 39 |
4 of 4 measures available
Facts
| market cap | $2B |
| free cash flow | $160.6M |
| employees | 890 |
| first trade | 2005-02-10 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2026 | 2025 | 2024 | 2023 |
| diluted eps | 3.91 | 4.29 | 4.17 | -1.65 |
| free cash flow | $246.4M | $243.3M | $239.4M | $221.9M |
| net income | $190.3M | $214.6M | $209.3M | -$82.3M |
| revenue | $1.09B | $1.14B | $1.13B | $1.13B |
| unusual items | $0 | -$12.5M | $0 | -$370.2M |